Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 154,207
  • Shares Outstanding, K 79,900
  • Annual Sales, $ 0 K
  • Annual Income, $ -20,840 K
  • EBIT $ -24 M
  • EBITDA $ -23 M
  • 60-Month Beta 0.91
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.11

Options Overview Details

View History
  • Implied Volatility 175.60% ( +21.97%)
  • Historical Volatility 48.83%
  • IV Percentile 56%
  • IV Rank 14.46%
  • IV High 857.83% on 12/26/23
  • IV Low 60.32% on 06/04/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 63
  • Volume Avg (30-Day) 204
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 8,070
  • Open Int (30-Day) 6,712

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.11
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5600 +32.69%
on 10/09/24
2.2400 -7.59%
on 11/07/24
+0.1800 (+9.52%)
since 10/07/24
3-Month
1.5600 +32.69%
on 10/09/24
2.6300 -21.29%
on 09/13/24
+0.1500 (+7.81%)
since 08/07/24
52-Week
0.7200 +187.50%
on 11/10/23
3.1200 -33.65%
on 06/12/24
+1.2300 (+146.43%)
since 11/07/23

Most Recent Stories

More News
Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis

MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected to run concurrently with the Company's planned Phase...

CRDL.TO : 2.90 (+7.81%)
CRDL : 2.0700 (+7.25%)
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

Oakville, Ontario--(Newsfile Corp. - October 11, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.90 (+7.81%)
CRDL : 2.0700 (+7.25%)
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Oakville, Ontario--(Newsfile Corp. - October 10, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.90 (+7.81%)
CRDL : 2.0700 (+7.25%)
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares

Oakville, Ontario--(Newsfile Corp. - October 9, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.90 (+7.81%)
CRDL : 2.0700 (+7.25%)
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares

Toronto, Ontario--(Newsfile Corp. - October 8, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.90 (+7.81%)
CRDL : 2.0700 (+7.25%)
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis

Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research...

CRDL.TO : 2.90 (+7.81%)
CRDL : 2.0700 (+7.25%)
Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18, 2024Toronto, Ontario--(Newsfile Corp. - September...

CRDL : 2.0700 (+7.25%)
CRDL.TO : 2.90 (+7.81%)
1 Cannabis ETF for Penny Stock Traders to Consider

The AdvisorShares Pure Cannabis ETF (YOLO) is gaining attention from penny stock traders due to its low price of under $5 per share, offering a cost-effective way to tap into the potential growth of the...

YOLO : 2.86 (+2.19%)
MSOS : 5.22 (+5.03%)
GTBIF : 9.2500 (+3.51%)
TCNNF : 7.7700 (+7.92%)
CURLF : 2.2541 (+3.59%)
VRNOF : 2.0400 (-8.52%)
CRLBF : 1.2799 (+11.78%)
VFF : 0.8870 (+10.88%)
HITI : 2.72 (+2.26%)
SNDL : 2.06 (unch)
CRDL : 2.0700 (+7.25%)
5 Biotech Stocks Under $10 With Multibagger Potential

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

ADCT : 2.93 (-8.44%)
$SPX : 5,973.10 (+0.74%)
RZLT : 5.72 (-1.55%)
TRVI : 2.90 (-6.45%)
ELEV : 0.5771 (+4.93%)
CRDL : 2.0700 (+7.25%)
Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL : 2.0700 (+7.25%)
CRDL.TO : 2.90 (+7.81%)

Business Summary

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

See More

Key Turning Points

3rd Resistance Point 2.5800
2nd Resistance Point 2.4100
1st Resistance Point 2.2400
Last Price 2.0700
1st Support Level 1.9000
2nd Support Level 1.7300
3rd Support Level 1.5600

See More

52-Week High 3.1200
Fibonacci 61.8% 2.2000
Last Price 2.0700
Fibonacci 50% 1.9200
Fibonacci 38.2% 1.6400
52-Week Low 0.7200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar